Literature DB >> 20551303

Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.

Lisa W Chu1, Tamra E Meyer, Qizhai Li, Idan Menashe, Kai Yu, Philip S Rosenberg, Wen-Yi Huang, Sabah M Quraishi, Rudolf Kaaks, Jocelyn M Weiss, Richard B Hayes, Stephen J Chanock, Ann W Hsing.   

Abstract

BACKGROUND: Genome-wide association studies have identified multiple independent regions on chromosome 8q24 that are associated with cancers of the prostate, breast, colon, and bladder.
METHODS: To investigate their biological basis, we examined the possible association between 164 single nucleotide polymorphisms (SNPs) in the 8q24 risk regions spanning 128,101,433-128,828,043 bp, and serum androgen (testosterone, androstenedione, 3alphadiol G, and bioavailable testosterone), and sex hormone-binding globulin levels in 563 healthy, non-Hispanic, Caucasian men (55-74 years old) from a prospective cohort study (the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial). Age-adjusted linear regression models were used to determine the association between the SNPs in an additive genetic model and log-transformed biomarker levels.
RESULTS: Three adjacent SNPs centromeric to prostate cancer risk-region 2 (rs12334903, rs1456310, and rs980171) were associated with testosterone (P < 1.1 x 10(-3)) and bioavailable testosterone (P < 6.3 x 10(-4)). Suggestive associations were seen for a cluster of nine SNPs in prostate cancer risk region 1 and androstenedione (P < 0.05).
CONCLUSIONS: These preliminary findings require confirmation in larger studies but raise the intriguing hypothesis that genetic variations in the 8q24 cancer risk regions might correlate with androgen levels. IMPACT: These results might provide some clues for the strong link between 8q24 and prostate cancer risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20551303      PMCID: PMC2901401          DOI: 10.1158/1055-9965.EPI-10-0101

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

2.  A common variant associated with prostate cancer in European and African populations.

Authors:  Laufey T Amundadottir; Patrick Sulem; Julius Gudmundsson; Agnar Helgason; Adam Baker; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Jean-Baptiste Cazier; Jesus Sainz; Margret Jakobsdottir; Jelena Kostic; Droplaug N Magnusdottir; Shyamali Ghosh; Kari Agnarsson; Birgitta Birgisdottir; Louise Le Roux; Adalheidur Olafsdottir; Thorarinn Blondal; Margret Andresdottir; Olafia Svandis Gretarsdottir; Jon T Bergthorsson; Daniel Gudbjartsson; Arnaldur Gylfason; Gudmar Thorleifsson; Andrei Manolescu; Kristleifur Kristjansson; Gudmundur Geirsson; Helgi Isaksson; Julie Douglas; Jan-Erik Johansson; Katarina Bälter; Fredrik Wiklund; James E Montie; Xiaoying Yu; Brian K Suarez; Carole Ober; Kathleen A Cooney; Henrik Gronberg; William J Catalona; Gudmundur V Einarsson; Rosa B Barkardottir; Jeffrey R Gulcher; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2006-05-07       Impact factor: 38.330

3.  Multiple regions within 8q24 independently affect risk for prostate cancer.

Authors:  Christopher A Haiman; Nick Patterson; Matthew L Freedman; Simon R Myers; Malcolm C Pike; Alicja Waliszewska; Julie Neubauer; Arti Tandon; Christine Schirmer; Gavin J McDonald; Steven C Greenway; Daniel O Stram; Loic Le Marchand; Laurence N Kolonel; Melissa Frasco; David Wong; Loreall C Pooler; Kristin Ardlie; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Esther M John; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

4.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

5.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.

Authors:  Meredith Yeager; Nick Orr; Richard B Hayes; Kevin B Jacobs; Peter Kraft; Sholom Wacholder; Mark J Minichiello; Paul Fearnhead; Kai Yu; Nilanjan Chatterjee; Zhaoming Wang; Robert Welch; Brian J Staats; Eugenia E Calle; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Edward Giovannucci; Walter C Willett; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; Edward P Gelmann; Margaret Tucker; Daniela S Gerhard; Joseph F Fraumeni; Robert Hoover; David J Hunter; Stephen J Chanock; Gilles Thomas
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

6.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

7.  Circadian variation in testosterone, sex hormone-binding globulin, and calculated non-sex hormone-binding globulin bound testosterone in healthy young and elderly men.

Authors:  S R Plymate; J S Tenover; W J Bremner
Journal:  J Androl       Date:  1989 Sep-Oct

8.  Control of circadian and episodic variations of adrenal androgens secretion in man.

Authors:  C Lejeune-Lenain; E Van Cauter; D Désir; M Beyloos; J R Franckson
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

9.  A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men.

Authors:  Paul D Morris; Chris J Malkin; Kevin S Channer; T Hugh Jones
Journal:  Eur J Endocrinol       Date:  2004-08       Impact factor: 6.664

10.  Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

Authors:  Meredith Yeager; Nilanjan Chatterjee; Julia Ciampa; Kevin B Jacobs; Jesus Gonzalez-Bosquet; Richard B Hayes; Peter Kraft; Sholom Wacholder; Nick Orr; Sonja Berndt; Kai Yu; Amy Hutchinson; Zhaoming Wang; Laufey Amundadottir; Heather Spencer Feigelson; Michael J Thun; W Ryan Diver; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Fredrick R Schumacher; Geraldine Cancel-Tassin; Olivier Cussenot; Antoine Valeri; Gerald L Andriole; E David Crawford; Christopher A Haiman; Brian Henderson; Laurence Kolonel; Loic Le Marchand; Afshan Siddiq; Elio Riboli; Timothy J Key; Rudolf Kaaks; William Isaacs; Sarah Isaacs; Kathleen E Wiley; Henrik Gronberg; Fredrik Wiklund; Pär Stattin; Jianfeng Xu; S Lilly Zheng; Jielin Sun; Lars J Vatten; Kristian Hveem; Merethe Kumle; Margaret Tucker; Daniela S Gerhard; Robert N Hoover; Joseph F Fraumeni; David J Hunter; Gilles Thomas; Stephen J Chanock
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

View more
  6 in total

1.  The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer.

Authors:  Heba S Omar; Olfat G Shaker; Yasser H Nassar; Samar A Marzouk; Mohamed S ElMarzouky
Journal:  Mol Cell Biochem       Date:  2015-02-28       Impact factor: 3.396

2.  Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Authors:  Konstantinos K Tsilidis; Ruth C Travis; Paul N Appleby; Naomi E Allen; Sara Lindstrom; Fredrick R Schumacher; David Cox; Ann W Hsing; Jing Ma; Gianluca Severi; Demetrius Albanes; Jarmo Virtamo; Heiner Boeing; H Bas Bueno-de-Mesquita; Mattias Johansson; J Ramón Quirós; Elio Riboli; Afshan Siddiq; Anne Tjønneland; Dimitrios Trichopoulos; Rosario Tumino; J Michael Gaziano; Edward Giovannucci; David J Hunter; Peter Kraft; Meir J Stampfer; Graham G Giles; Gerald L Andriole; Sonja I Berndt; Stephen J Chanock; Richard B Hayes; Timothy J Key
Journal:  Am J Epidemiol       Date:  2012-03-29       Impact factor: 4.897

Review 3.  Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.

Authors:  Georgios Gakis; Arnulf Stenzl
Journal:  World J Urol       Date:  2013-02-09       Impact factor: 4.226

4.  Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.

Authors:  Ruixia Huang; Yuanyuan Ma; Ruth Holm; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

5.  Genetic polymorphism of the OPG gene associated with breast cancer.

Authors:  Jasmin Teresa Ney; Ingolf Juhasz-Boess; Frank Gruenhage; Stefan Graeber; Rainer Maria Bohle; Michael Pfreundschuh; Erich Franz Solomayer; Gunter Assmann
Journal:  BMC Cancer       Date:  2013-01-31       Impact factor: 4.430

6.  RANK rs1805034 T>C polymorphism is associated with susceptibility of esophageal cancer in a Chinese population.

Authors:  Jun Yin; Liming Wang; Weifeng Tang; Xu Wang; Lu Lv; Aizhong Shao; Yijun Shi; Guowen Ding; Suocheng Chen; Haiyong Gu
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.